Grant: Collaborative Health Research Projects
Université Laval
$188,500.00
Coherent raman tissue spectroscopy for in vivo disease diagnosis
FY 2008-09
Summary
The survival rate of cancer patients is better when a diagnosis is made early and treatment is carried out promptly. Hence, there has been a large effort in the development of optical diagnostics for different clinical applications over the last 10-15 years, including techniques based on light absorption by tissues, elastic scattering, fluorescence (endogenous and with exogenous administered fluorophores). Each of these techniques has its own strengths and limitations, depending on factors such as the strength of the signals, speed, resolution (spatial, temporal and/or spectral) and sensitivity and specificity to altered tissue properties (structural, biochemical, molecular). Near Infrared Raman Spectroscopy (NIRS) has the specific advantage that it is sensitive to changes in the tissue biochemistry, without additional contrast agents or drugs. It is based on the phenomenon of inelastic scattering of light by molecules and probes the vibrational states of (bio)molecules. NIRS has been investigated intensely especially in the past 10 years, for non- or minimally-invasive tissue clinical diagnostics ("optical biopsies"), and has been very helpful cancer diagnosis and surgery guidance, but has encountered important roadblocks for widespread clinical applications mainly related to its low signal strength. The coherent Raman effect (CARS) can be used to generate a Raman signal much stronger than in NIRS without problems related to endogenous fluorescence. The basic assumption in this proposal is that this novel optical technique will provide the necessary improvements over spontaneous Raman to permit its use for coarse and/or fine imaging (higher sampling or biochemical maps) in the clinic for non invasive cancer diagnosis. To prove this hypothesis, we will construct a broadband CARS spectroscopy system and compare its performance to NIRS in tissue samples and animal models of cancer. Once the superiority of CARS spectroscopy over spontaneous Raman has been demonstrated, we will confirm the technical feasibility of CARS spectroscopy in vivo in a pre-clinical trial with a prototype having limited imaging capabilities.
Program
Collaborative Health Research Projects
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
337441-2007
Name nom
Côté, Daniel
Department département
Physique, génie physique et optique
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2007
Award amount
188500
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
2 & 3
Nb partie
3
Application title
Coherent raman tissue spectroscopy for in vivo disease diagnosis
Keyword
NA
Application summary
The survival rate of cancer patients is better when a diagnosis is made early and treatment is carried out promptly. Hence, there has been a large effort in the development of optical diagnostics for different clinical applications over the last 10-15 years, including techniques based on light absorption by tissues, elastic scattering, fluorescence (endogenous and with exogenous administered fluorophores). Each of these techniques has its own strengths and limitations, depending on factors such as the strength of the signals, speed, resolution (spatial, temporal and/or spectral) and sensitivity and specificity to altered tissue properties (structural, biochemical, molecular). Near Infrared Raman Spectroscopy (NIRS) has the specific advantage that it is sensitive to changes in the tissue biochemistry, without additional contrast agents or drugs. It is based on the phenomenon of inelastic scattering of light by molecules and probes the vibrational states of (bio)molecules. NIRS has been investigated intensely especially in the past 10 years, for non- or minimally-invasive tissue clinical diagnostics ("optical biopsies"), and has been very helpful cancer diagnosis and surgery guidance, but has encountered important roadblocks for widespread clinical applications mainly related to its low signal strength. The coherent Raman effect (CARS) can be used to generate a Raman signal much stronger than in NIRS without problems related to endogenous fluorescence. The basic assumption in this proposal is that this novel optical technique will provide the necessary improvements over spontaneous Raman to permit its use for coarse and/or fine imaging (higher sampling or biochemical maps) in the clinic for non invasive cancer diagnosis. To prove this hypothesis, we will construct a broadband CARS spectroscopy system and compare its performance to NIRS in tissue samples and animal models of cancer. Once the superiority of CARS spectroscopy over spontaneous Raman has been demonstrated, we will confirm the technical feasibility of CARS spectroscopy in vivo in a pre-clinical trial with a prototype having limited imaging capabilities.